1. Bartolazzi, A., Peach, R., Aruffo, A., and Stamenkovic, I. Interaction between CD44
26.
and hyaluronate is directly implicated in the regulation of tumor development. J. Exp.
Med., 180: 53– 66, 1994.
2. Culty, M., Shirazi, M., Thompson, E. W., and Underhill, C. B. Binding and degra- 27.
dation of hyaluronan by human breast cancer cell lines expressing different forms of
CD44: correlation with invasive potential. J. Cell. Physiol. 160: 275–286, 1994. 28.
3. Okada, H., Yoshida, J., Sokabe, M., Wakabayashi, T., and Hagiwara, M. Suppression
of CD44 expression decreases migration and invasion of human glioma cells. Int. J.
Cancer, 66: 255–260, 1996.
4. Turley, E. A., Belch, A. J., Poppema, S., and Pilarski, L. M. Expression and function 29.
of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood, 81: 446 – 453, 1993. 30.
5. Zhang, H., Kelly, G., Zerillo, C., Jaworski, D. M., and Hockfield, S. Expression of a
cleaved brain-specific extracellular matrix protein mediates glioma cell invasion in
vivo. J. Neurosci., 18: 2370 –2376, 1998.
6. Doege, K., Hassell, J. R., Caterson, B., and Yamada, Y. Link protein cDNA sequence
31.
reveals a tandemly repeated protein structure. Proc. Natl. Acad. Sci. USA, 83:
3761–3765, 1986.
7. Yamada, H., Watanabe, K., Shimonaka, M., and Yamaguchi, Y. Molecular cloning of
brevican, a novel proteoglycan of the aggrecan/versican family. J. Biol. Chem., 269:
10119 –10126, 1994. 32.
8. Rauch, U., Karthikeyan, L., Maurel, P., Margolis, R. U., and Margolis, R. K. Cloning
and primary structure of neurocan, a developmentally regulated, aggregating chon- 33.
droitin sulfate proteoglycan of brain. J. Biol. Chem., 267: 19536 –19547, 1992.
9. Perides, G., Lane, W. S., Andrews, D., Dahl, D., and Bignami, A. Isolation and partial
characterization of a glial hyaluronate-binding protein. J. Biol. Chem., 264: 5981– 34.
5987, 1989.
10. Zimmermann, D. R., and Ruoslahti, E. Multiple domains of a large fibroblast
proteoglycan, versican. EMBO J., 8: 2975–2981, 1989.
11. Delpech, B., Girard, N., Olivier, A., Maingonnat, C., Van Driesche, G., Van Beemen, 35.
J., Bertrand, P., Duval, C., Delpech, A., and Bourguignon, J. The origin of hyaluronectin in human tumors. Int. J. Cancer, 72: 942–948, 1997.
12. Naor, D., Sionov, R. V., and Ish-Shalom, D. CD44: Structure, function, and associ-36.
ation with the malignant process. Adv. Cancer Res., 71: 241–319, 1997.
13. Jaworski, D. M., Kelly, G. M., and Hockfield, S. BEHAB, a new member of the
proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to
37.
the brain. J. Cell. Biol., 125: 495–509, 1994.
14. Seidenbecher, C. I., Richter, K., Rauch, U., Fassler, R., Garner, C. C., and Gundelfinger, E. D. Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as secreted
and cell surface glycosylphosphatidyl-inositol-anchored isoforms. J. Biol. Chem., 38.
270: 27206 –27212, 1995.
15. Hardwick, C., Hoare, K., Owens, R., Hohn, H. P., Hook, M., Moore, D., Cripps, V., 39.
Austen, L., Nance, D. M., and Turley, E. A. Molecular cloning of a novel hyaluronan
receptor that mediates tumor cell motility. J. Cell Biol., 117: 1343–1350, 1992.
